SS-31 (50 mg Vial)
Handling notes for SS-31 (50 mg Vial), supplied lyophilized. Covers the reconstitution volume and concentration it yields, U-100 syringe unit equivalents, per-protocol consumable counts and storage conditions.
CAT No:
CAS No:
Synonyms/Alias:SS-31
M.F/Formula:
M.W/Mr.:
Purity:Specification by inquiry
- Sequence, purity and scale confirmation
- CoA and technical documentation requests
- API, research and cosmetic peptide options
- Distributor and institution quotation support
Handling notes for SS-31 (50 mg Vial), supplied lyophilized. Covers the reconstitution volume and concentration it yields, U-100 syringe unit equivalents, per-protocol consumable counts and storage conditions.
Quickstart
Reconstitute: Add 3.0 mL bacteriostatic water → ~16.67 mg/mL concentration for convenient dosing.
Typical daily range: 5–10 mg once daily (gradual titration); advanced protocols may reach 15–20 mg/day under supervision.
Easy measuring: At 16.67 mg/mL, 1 unit = 0.01 mL ≈ 167 mcg on a U‑100 insulin syringe.
Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F); use within 4 weeks.
Notes
Practical considerations for consistency, safety, and tolerability. Use new sterile insulin syringes for each injection; dispose in a sharps container immediately after use. Rotate injection sites systematically (abdomen, thighs, upper arms) to reduce local irritation and prevent lipohypertrophy [14]. Inject slowly over several seconds; wait briefly before withdrawing the needle to prevent leakage. Mild injection‑site reactions (redness, itching, transient discomfort) are the most common side effects reported in clinical trials [4] [6]; these typically resolve within hours. Document daily do
Single peptide protocol reference : Available for related research, development or formulation inquiry workflows.: Available for related research, development or formulation inquiry workflows.
Reconstitution and handling reference : Available for related research, development or formulation inquiry workflows.: Available for related research, development or formulation inquiry workflows.
Research-use documentation inquiry : Available for related research, development or formulation inquiry workflows.: Available for related research, development or formulation inquiry workflows.
Peptide Vials (SS‑31, 50 mg each): 8 weeks (Standard: 5–10 mg/day) ≈ 10 vials
12 weeks (Standard maintenance at 10 mg/day) ≈ 16 vials
12 weeks (Advanced: escalating to 15 mg/day) ≈ 21 vials
Insulin Syringes (U‑100, 1 mL capacity): Per week (standard dosing): 7 syringes (1/day)
8 weeks: 56 syringes
12 weeks: 84 syringes
Advanced protocols with split injections may require 2 syringes per day for 20 mg doses
Bacteriostatic Water (30 mL bottles): Use 3.0 mL per vial for reconstitution. 8 weeks (10 vials): 30 mL → 1 × 30 mL bottle
12 weeks (16 vials): 48 mL → 2 × 30 mL bottles
12 weeks (21 vials, advanced): 63 mL → 3 × 30 mL bottles
Alcohol Swabs: One for the vial stopper + one for the injection site each day. Per week: 14 swabs (2/day)
8 weeks: 112 swabs → recommend 2 × 100‑count boxes
12 weeks: 168 swabs → recommend 2 × 100‑count boxes
Send product, purity, quantity, destination and documentation requirements. Our team will follow up through online consultation or email.
WhatsApp: +852 52102460 +1 4422847013
Address: Huangpu District, Guangzhou, China